Methodological issues with the risk of relapse study in patients with multiple sclerosis after yellow fever vaccination.

Authors:
Address:
Journal:

Publication:

abstract

Related Articles
Yellow fever vaccination and increased relapse rate in travelers with multiple sclerosis.
Arch Neurol. 2011
Yellow fever vaccination and increased relapse rate in travelers with multiple sclerosis.
Farez MF, Correale J. Arch Neurol. 2011 Oct; 68(10):1267-71. Epub 2011 Jun 13.
Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial.
PLoS One. 2008
Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial.
Roukens AH, Vossen AC, Bredenbeek PJ, van Dissel JT, Visser LG. PLoS One. 2008 Apr 23; 3(4):e1993. Epub 2008 Apr 23.
Review Acute viscerotropic disease following vaccination against yellow fever.
Trans R Soc Trop Med Hyg. 2007
Review Acute viscerotropic disease following vaccination against yellow fever.
Hayes EB. Trans R Soc Trop Med Hyg. 2007 Oct; 101(10):967-71. Epub 2007 Jul 31.
Review Yellow fever vaccine: past, present and future.
Expert Opin Biol Ther. 2008
Review Yellow fever vaccine: past, present and future.
Roukens AH, Visser LG. Expert Opin Biol Ther. 2008 Nov; 8(11):1787-95.
Current status of the Arilvax; yellow fever vaccine.
Expert Rev Vaccines. 2004
Current status of the Arilvax; yellow fever vaccine.
Barrett AD. Expert Rev Vaccines. 2004 Aug; 3(4):413-20.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.